Dynagas LNG Partners LP Announces Results of 2018 Annual General Meeting of Limited Partners
MONACO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”) conducted its Annual General Meeting […]
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA®
CAMBRIDGE, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform […]
Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy
CAMBRIDGE, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) — Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on […]
TTM Technologies, Inc. Production Site in Guangzhou, China was Recognized as a Green Factory
COSTA MESA, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (Nasdaq:TTMI), a leading global printed circuit board (“PCB”) […]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment […]
OceanFirst Bank Announces Executive Management Team Appointments
RED BANK, N.J., Dec. 03, 2018 (GLOBE NEWSWIRE) — OceanFirst Financial Corp. (NASDAQ:OCFC “OceanFirst”), the holding company for OceanFirst Bank […]
Auramex Closes Private Placements
Not for dissemination in the United States or through U.S. newswires VANCOUVER, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) — […]
LPL Financial Announces the Acquisition of AdvisoryWorld
Accelerates LPL’s Delivery of Digital Capabilities to Help Advisors Grow and Increase Efficiency SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) […]
David Prince Named EVP, Head of Commercial Banking at Heartland Financial USA, Inc.
DUBUQUE, Iowa, Dec. 03, 2018 (GLOBE NEWSWIRE) — Heartland Financial USA, Inc. (NASDAQ: HTLF) announced today that it has named […]
Fate Therapeutics Secures Exclusive Option to Novel Humanized anti-BCMA CAR Constructs for Development of iPSC-derived Cell Products
Agreement with Max Delbrück Center Provides Access to Broad Intellectual Property Portfolio of Humanized Antibody Fragments and Antigen-Binding Domains Targeting […]
